Valeant Pharmaceuticals International (NYSE: VRX) today announced that members of its senior management team will make a presentation at the UBS Global Life Sciences Conference on Wednesday, September 24, 2008 at 11:00 a.m. EDT. The conference will be held at The Grand Hyatt Hotel in New York, NY.

A live webcast and audio archive of the presentation will be available on the company’s Web site at www.valeant.com [1]. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation’s start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant

Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com [2].